Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

View source ↗

Summary

An observational study to evaluate how well a subsequent treatment works in adults with unresectable hepatocellular carcinoma after prior therapy with atezolizu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atezolizumab (atezolizumab)
  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Bayer | Conditions: Unresectable Hepatocellular Carcinoma | Status: RECRUITING